Intellia Therapeutics, Inc.

A medial security in the Health Care that looks (login to see)

Yahoo! Profile

NTLA

Pharmaceutical Preparation Manufacturing
Weighting

Weak Growth

Lead | Lag

Medial

Options

Buying (0.43)

P/E Ratio

5.42

Free Cash Flow

Negative (-6.64)

Dividend

none

Begin Today!

Have access to custom plans you can create, auto-portfolios and much more!




NO OBLIGATION TO BUY